Page last updated: 2024-10-22

amitriptyline and Gastroparesis

amitriptyline has been researched along with Gastroparesis in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lacy, BE1
Saito, YA1
Camilleri, M1
Bouras, E1
DiBaise, JK1
Herrick, LM1
Szarka, LA1
Tilkes, K1
Zinsmeister, AR1
Talley, NJ1

Trials

1 trial available for amitriptyline and Gastroparesis

ArticleYear
Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.
    The American journal of gastroenterology, 2018, Volume: 113, Issue:2

    Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Dyspepsia; Female; Gastric Emptying; Gastro

2018